Neurones Valuation
| NRO Stock | EUR 35.55 1.05 3.04% |
At this time, the firm appears to be overvalued. Neurones secures a last-minute Real Value of €28.8 per share. The latest price of the firm is €35.55. Our model forecasts the value of Neurones from analyzing the firm fundamentals such as Current Valuation of 589.32 M, profit margin of 0.06 %, and Return On Equity of 0.15 as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Neurones' valuation include:
Price Book 2.2537 | Enterprise Value | Enterprise Value Ebitda 5.6275 | Price Sales 1.0392 | Trailing PE 17.0913 |
Overvalued
Today
Please note that Neurones' price fluctuation is very steady at this time. Calculation of the real value of Neurones is based on 3 months time horizon. Increasing Neurones' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Neurones is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Neurones Stock. However, Neurones' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 35.55 | Real 28.8 | Hype 34.78 | Naive 33.7 |
The real value of Neurones Stock, also known as its intrinsic value, is the underlying worth of Neurones Company, which is reflected in its stock price. It is based on Neurones' financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Neurones' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Neurones helps investors to forecast how Neurones stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Neurones more accurately as focusing exclusively on Neurones' fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Neurones' intrinsic value based on its ongoing forecasts of Neurones' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Neurones' closest peers. If more than one evaluation category is relevant for Neurones we suggest using both methods to arrive at a better estimate.
Neurones Cash |
|
Neurones Total Value Analysis
Neurones is now estimated to have takeover price of 589.32 M with market capitalization of 864.79 M, debt of 42.02 M, and cash on hands of 169.6 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Neurones fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
589.32 M | 864.79 M | 42.02 M | 169.6 M |
Neurones Investor Information
About 70.0% of the company outstanding shares are owned by corporate insiders. The book value of Neurones was now reported as 15.29. The company last dividend was issued on the 11th of June 2025. Based on the key indicators related to Neurones' liquidity, profitability, solvency, and operating efficiency, Neurones is not in a good financial situation at this time. It has a very high probability of going through financial hardship in March.| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Operating Profit Margin | 0.0753 | 0.0865 |
|
| |||||
| Total Cash From Operating Activities | 101.9 M | 97 M |
|
| |||||
| Operating Income | 94.1 M | 89.6 M |
|
|
Neurones Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Neurones has an asset utilization ratio of 111.67 percent. This suggests that the Company is making €1.12 for each dollar of assets. An increasing asset utilization means that Neurones is more efficient with each dollar of assets it utilizes for everyday operations.Neurones Profitability Analysis
Based on Neurones' profitability indicators, Neurones may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in March. Profitability indicators assess Neurones' ability to earn profits and add value for shareholders.Net Income | First Reported 2001-12-31 | Previous Quarter 28 M | Current Value 22.7 M | Quarterly Volatility 6.8 M |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.62 | 0.55 |
|
| |||||
| Net Profit Margin | 0.0467 | 0.0583 |
|
| |||||
| Operating Profit Margin | 0.0753 | 0.0865 |
|
| |||||
| Pretax Profit Margin | 0.0791 | 0.0978 |
|
| |||||
| Return On Assets | 0.053 | 0.0651 |
|
| |||||
| Return On Equity | 0.088 | 0.12 |
|
|
For Neurones profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Neurones to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Neurones utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Neurones's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Neurones over time as well as its relative position and ranking within its peers.
Neurones Earnings per Share Projection vs Actual
By analyzing Neurones' earnings estimates, investors can diagnose different trends across Neurones' analyst sentiment over time as well as compare current EPS estimates against different timeframes. Please be aware that the consensus of earnings estimates for Neurones is based on EPS before non-recurring items and includes expenses related to employee stock options.Neurones Ownership Allocation
Neurones maintains a total of 24.32 Million outstanding shares. Neurones secures majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 69.6 % of Neurones outstanding shares that are owned by insiders conveys that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.Neurones Profitability Analysis
The company reported the revenue of 810.4 M. Net Income was 63.23 M with profit before overhead, payroll, taxes, and interest of 401.23 M.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Neurones' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Neurones and how it compares across the competition.
About Neurones Valuation
The stock valuation mechanism determines Neurones' current worth on a weekly basis. Our valuation model uses a comparative analysis of Neurones. We calculate exposure to Neurones's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Neurones's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 447.1 M | 469.4 M | |
| Pretax Profit Margin | 0.10 | 0.08 | |
| Operating Profit Margin | 0.09 | 0.08 | |
| Net Profit Margin | 0.06 | 0.05 | |
| Gross Profit Margin | 0.55 | 0.62 |
Neurones Quarterly Retained Earnings |
|
Complementary Tools for Neurones Stock analysis
When running Neurones' price analysis, check to measure Neurones' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Neurones is operating at the current time. Most of Neurones' value examination focuses on studying past and present price action to predict the probability of Neurones' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Neurones' price. Additionally, you may evaluate how the addition of Neurones to your portfolios can decrease your overall portfolio volatility.
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |